Why the study?
Does persistent allopeptide reactivity and epitope spreading predict the development of coronary artery vasculopathy in heart allograft recipients?
Population
34 heart allograft recipients
Comparison
Persistent allopeptide reactivity and epitope… vs Patients who showed no alloreactivity after the…
Design
Cohort
Follow-up
up to 36 months
Authors
Loading...
Persistent alloreactivity may aid vasculopathy risk stratification post-heart transplant; leaves open whether targeting indirect allorecognition improves outcomes.
Does persistent allopeptide reactivity and epitope spreading predict the development of coronary artery vasculopathy in heart allograft recipients?
Persistent allopeptide reactivity and epitope spreading are associated with the development of coronary artery vasculopathy, suggesting a role for the indirect allorecognition pathway in chronic heart allograft rejection.
Ciubotariu et al. (1998) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: